IBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Impact Biomedical Inc (IBO) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company faces significant financial challenges, including a 'going concern' qualification, declining net income, and EPS, as well as limited positive trading signals. The technical indicators, while showing some bullish trends, are overshadowed by the company's financial instability and negative market sentiment.
The MACD is positive and expanding, indicating a bullish trend. The RSI is in the neutral zone at 73.937, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock price has dropped significantly in pre-market and post-market trading, suggesting bearish sentiment. Key support and resistance levels are Pivot: 0.623, R1: 0.695, S1: 0.551, R2: 0.74, S2: 0.506.
The company is progressing with its merger with Dr. Ashley's Ltd., expected to complete by July 1, 2026.
The 'going concern' qualification indicates financial uncertainty, which could hinder the company's ability to secure additional financing. This has negatively impacted investor confidence. The company's financial performance shows a significant decline in net income (-119.35% YoY) and EPS (-102.54% YoY).
In Q4 2025, revenue remained flat at 7000 (0.00% YoY). Net income dropped significantly to 5245000 (-119.35% YoY), and EPS fell to 0.06 (-102.54% YoY). Gross margin increased to -4028.57, but this is still negative, reflecting poor financial health.
No analyst rating or price target changes are available for this stock.
